4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-039836
Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CANNON JAMES ANTHONY Director | 2017-06-12 | Option exercise | +15,000 | $4.85 | $72,750 | 367,502 | D |
| Derivatives | |||||||
| CANNON JAMES ANTHONY Director | 2017-06-12 | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…